Figure 8.
Evaluation of cytotoxic activity of selected CK2-HDAC dual inhibitors towards human leukemia cells of the HL-60 line and its drug-resistant sublines HL-60/adr (MRP-1 overexpression) and HL-60/vinc (P-glycoprotein overexpression). Trypan blue assay, 24 h incubation. Means and SD of at least three experiments in triplicate are shown.
